Page 492 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer
P. 492

Appendix Table C4.2. Comparison between watchful waiting and radical prostatectomy (continued)
                                        Author, Year         Study name       Comparison           Outcome            Followup      Sample size      Results                          Factors included in the
                                        [Pubmed ID]          /Database                             definition/        (yr)          per group                                         model
                                                                                                   measurement
                                        Study design                                               instrument
                                        Wong  208            SEER-            RP vs.               Overall survival   12 yr         RP: 13,292       HR=0.50 (0.47, 0.53)             PS: age at diagnosis,
                                        2006                 Medicare         observation          = interval from                                                                    SEER site, year of
                                        17164454                                                   the date of                      Observation:                                      diagnosis, tumor size,
                                                                                                   diagnosis to the                 12,608                                            tumor grade, marital
                                        Retrospective                                              Medicare dare                                                                      status, residence in an
                                        cohort                                                     of death.                                                                          urban setting, race,
                                                                                                   Patients were                                                                      income, educational
                                                                                                   censored at                                                                        achievement, and 44
                                                                                                   Dec. 20, 2002.                                                                     categorical variables
                                                                                                                                                                                      encoding comorbidities.
                                                                                                                                                                                      The authors reported a
                                                                                                                                                                                      statistically significant
                                                                                                                                                                                      interaction between
                                                                                                                                                                                      tumor size and grade.

                                                                                                                                                                                      For treatment subgroups
                                                                                                                                                                                      (RP and radiation Tx)
                                                                                                                                                                                      separate PS were built
                                                                                                                                                                                      and used as covariates
                                                                                                                                                                                      in the Cox regression
                                                                                                                                                                                      models.
                                        Rice 232             CPDR             WW vs. RP            NR                 Mean:         WW without       Multivariable Cox                Age at diagnosis, PSA
                                        2011                 database                                                 WW, 5.3       secondary        proportional hazards model       at diagnosis,
                                        21872499                                                                      yr; yr; RP.   treatment:       predicting overall mortality:    race/ethnicity, number of
                                                                                                                      7.2 yr        214                                               comorbidities, T stage,
                                        Retrospective                                                                               WW with          WW without secondary Tx          and treatment groups
                                        cohort                                                                                      secondary        vs. RP (reference):              (RP, EBRT, WW with
                                                                                                                                    treatment:       HR=1.938 (1.185, 9.168),         secondary Tx; WW
                                                                                                                                    110              P=0.008                          without secondary Tx).
                                                                                                                                    RP: 194
                                                                                                                                                     WW with secondary Tx vs.
                                                                                                                                                     RP (reference): HR=0.807
                                                                                                                                                     (0.462, 1.407), P=0.45













                                                                                                                        C-164
   487   488   489   490   491   492   493   494   495   496   497